Get the Stockscreener App
3.17
0.31%
-0.01
Acelyrin Inc Stock (SLRN) Forecast
The Acelyrin Inc (SLRN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.9347, representing a -7.42% decrease from the current price of $3.17. The highest analyst price target is $3.3124, and the lowest is $2.5569.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SLRN Price Target
Average 8.8859
(+180.31% Upside)
Is Acelyrin Inc (SLRN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 27.95 | Buy |
| STOCH(9,6) | 13.32 | Buy |
| STOCHRSI(14) | 46.61 | Neutral |
| MACD(12,26) | -0.4931 | Sell |
| ADX(14) | 35.19 | Sell |
| William %R | -91.84 | Buy |
| CCI(14) | -51.67 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.304
Sell
|
3.3979
Sell
|
| MA20 |
3.831
Sell
|
3.7765
Sell
|
| MA50 |
4.9312
Sell
|
4.4378
Sell
|
| MA100 |
4.8704
Sell
|
4.8496
Sell
|
| MA200 |
5.1025
Sell
|
5.9269
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SLRN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on SLRN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 27.95 indicates that SLRN is oversold. This indicates that SLRN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 13.32 indicates that SLRN is oversold. This indicates that SLRN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.61 indicates that SLRN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 35.19 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -51.67 indicates that SLRN is still oversold but not to an extreme extent.
Long-term SLRN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Acelyrin Inc financial reports and earnings history, Acelyrin Inc (SLRN) stock could reach $21.57 by 2030, $172.37 by 2040 and $418.69 by 2050. See the projected annual prices until 2050 of the Acelyrin Inc stock below:
- Acelyrin Inc (SLRN) is expected to reach an average price of $142.74 in 2035, with a high prediction of $154.26 and a low estimate of $144.74. This indicates an $4,403% rise from the last recorded price of $3.17.
- Acelyrin Inc (SLRN) stock is projected to chart a bullish course in 2040, with an average price target of $161.91, representing an $5,007% surge from its current level. The forecast ranges from a conservative $162.28 to a sky-high $172.37.
- Our analysts predict Acelyrin Inc (SLRN) to jump 4,132% by 2045, soaring from $134.71 to an average price of $134.15, potentially reaching $147.67. While $134.71 is the low estimate, the potential upside is significant.
- Acelyrin Inc (SLRN) stock is expected to climb by 2050, reaching an average of $419.25, a $13,126% jump from its current level. However, a wide range of estimates exists, with high and low targets of $418.69 and $78.09, respectively, highlighting the market's uncertainty.
Acelyrin Inc Stock (SLRN) Year by Year Forecast
Acelyrin Inc Stock (SLRN) Price Forecast for 2025
Acelyrin Inc Stock (SLRN) is expected to reach an average price of $8.8859 in 2025, with a high prediction of $17.69 and a low estimate of $0.0769. This indicates an +180.31% rise from the last recorded price of $3.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.3069 | $2.5569 | $3.3124 | -27.23% |
| February, 2025 | $2.4929 | $1.7999 | $1.2084 | -21.36% |
| March, 2025 | $0.6511 | $0.1074 | $1.1011 | -79.46% |
| April, 2025 | $1.4136 | $0.2396 | $2.6936 | -55.41% |
| May, 2025 | $1.0376 | $1.0076 | $3.0406 | -67.27% |
| June, 2025 | $0.1816 | $0.0769 | $1.4961 | -94.27% |
| July, 2025 | $17.68 | $0.4501 | $14.44 | +457.70% |
| August, 2025 | $15.21 | $16.34 | $17.69 | +379.84% |
| September, 2025 | $11.49 | $13.49 | $13.64 | +262.55% |
| October, 2025 | $5.2779 | $6.5279 | $8.886 | +66.50% |
| November, 2025 | $1.0399 | $2.8399 | $2.4169 | -67.19% |
| December, 2025 | $15.45 | $1.9229 | $15.82 | +387.54% |
Acelyrin Inc Stock (SLRN) Price Forecast for 2026
The predicted value for Acelyrin Inc (SLRN) in 2026 is set at an average of $19.47. Estimates vary from a peak of $35.65 to a trough of $3.2898, indicating an +514.23% surge from the present price of $3.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $13.32 | $13.97 | $14.67 | +320.25% |
| February, 2026 | $12.70 | $13.02 | $13.26 | +300.60% |
| March, 2026 | $11.49 | $13.29 | $13.51 | +262.49% |
| April, 2026 | $10.89 | $10.56 | $10.98 | +243.40% |
| May, 2026 | $6.7078 | $7.1378 | $9.0088 | +111.60% |
| June, 2026 | $4.0198 | $4.2498 | $5.7008 | +26.81% |
| July, 2026 | $3.9948 | $4.0248 | $3.3728 | +26.02% |
| August, 2026 | $3.8168 | $3.8568 | $3.5468 | +20.40% |
| September, 2026 | $36.15 | $3.2898 | $33.69 | +1,040% |
| October, 2026 | $32.65 | $33.78 | $35.65 | +930.01% |
| November, 2026 | $27.90 | $29.90 | $30.83 | +780.11% |
| December, 2026 | $20.39 | $21.64 | $25.03 | +543.28% |
Acelyrin Inc Stock (SLRN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Acelyrin Inc (SLRN) is $30.32, with a high forecast of $53.61 and a low forecast of $7.0297. This indicates an +856.46% increase from the last price of $3.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $15.12 | $16.92 | $16.76 | +376.97% |
| February, 2027 | $28.97 | $15.74 | $28.87 | +813.81% |
| March, 2027 | $25.08 | $25.72 | $27.98 | +691.02% |
| April, 2027 | $23.42 | $23.74 | $24.75 | +638.75% |
| May, 2027 | $21.18 | $23.11 | $23.72 | +568.02% |
| June, 2027 | $19.28 | $19.21 | $20.41 | +508.16% |
| July, 2027 | $14.07 | $14.50 | $17.14 | +343.75% |
| August, 2027 | $10.34 | $10.57 | $12.80 | +226.33% |
| September, 2027 | $9.0272 | $9.0572 | $9.4392 | +184.77% |
| October, 2027 | $7.8152 | $7.8552 | $8.0517 | +146.54% |
| November, 2027 | $52.17 | $7.0297 | $52.94 | +1,546% |
| December, 2027 | $50.09 | $51.22 | $53.61 | +1,480% |
Acelyrin Inc Stock (SLRN) Price Forecast for 2028
In 2028, Acelyrin Inc (SLRN) is projected to reach an average price of $29.93, with a high projection of $48.01 and a low estimate of $11.85. This indicates an +844.19% rise from the last price of $3.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $44.31 | $46.31 | $48.01 | +1,298% |
| February, 2028 | $37.02 | $38.29 | $41.18 | +1,068% |
| March, 2028 | $29.20 | $31.00 | $34.54 | +821.13% |
| April, 2028 | $42.01 | $29.57 | $41.99 | +1,225% |
| May, 2028 | $36.83 | $37.47 | $40.77 | +1,062% |
| June, 2028 | $34.14 | $34.46 | $36.25 | +976.90% |
| July, 2028 | $30.86 | $32.79 | $33.92 | +873.56% |
| August, 2028 | $27.67 | $27.87 | $29.83 | +772.92% |
| September, 2028 | $21.43 | $21.86 | $25.28 | +575.89% |
| October, 2028 | $16.67 | $16.90 | $19.90 | +425.86% |
| November, 2028 | $14.06 | $14.09 | $15.51 | +343.52% |
| December, 2028 | $11.81 | $11.85 | $12.83 | +272.67% |
Acelyrin Inc Stock (SLRN) Price Forecast for 2029
The 2029 price forecast for Acelyrin Inc Stock (SLRN) is $41.48 on average, with a high prediction of $72.19 and a low estimate of $10.77. This represents an +1,209% increase from the previous price of $3.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $73.10 | $10.77 | $72.19 | +2,206% |
| February, 2029 | $67.53 | $68.66 | $71.57 | +2,030% |
| March, 2029 | $60.71 | $62.71 | $65.19 | +1,815% |
| April, 2029 | $52.39 | $53.66 | $57.33 | +1,553% |
| May, 2029 | $43.28 | $45.08 | $49.65 | +1,265% |
| June, 2029 | $55.06 | $43.39 | $55.29 | +1,637% |
| July, 2029 | $50.60 | $50.74 | $53.56 | +1,496% |
| August, 2029 | $44.86 | $45.18 | $48.27 | +1,315% |
| September, 2029 | $40.55 | $42.48 | $44.12 | +1,179% |
| October, 2029 | $36.06 | $36.26 | $39.26 | +1,038% |
| November, 2029 | $28.78 | $29.21 | $33.41 | +808.03% |
| December, 2029 | $22.99 | $23.22 | $27.00 | +625.38% |
Acelyrin Inc Stock (SLRN) Price Forecast for 2030
Acelyrin Inc Stock (SLRN) is expected to reach an average price of $52.97 in 2030, with a high forecast of $91.44 and a low forecast of $14.51. This signifies an +1,571% surge from the last price of $3.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $19.09 | $19.12 | $21.57 | +502.27% |
| February, 2030 | $15.81 | $15.85 | $17.60 | +398.80% |
| March, 2030 | $89.64 | $14.51 | $91.44 | +2,728% |
| April, 2030 | $87.65 | $89.59 | $89.52 | +2,665% |
| May, 2030 | $77.12 | $79.12 | $84.50 | +2,333% |
| June, 2030 | $67.76 | $69.03 | $73.48 | +2,038% |
| July, 2030 | $57.36 | $59.16 | $64.76 | +1,709% |
| August, 2030 | $68.11 | $57.21 | $68.60 | +2,048% |
| September, 2030 | $62.61 | $62.75 | $66.34 | +1,875% |
| October, 2030 | $55.58 | $55.90 | $60.02 | +1,653% |
| November, 2030 | $50.23 | $52.16 | $54.32 | +1,485% |
| December, 2030 | $44.85 | $45.17 | $48.69 | +1,315% |
0.10%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):